Published on Friday, December 14, 2018
Human Islet Phenotyping Program (HIPP) Data Release
Now available to IIDP investigators who have received islets from an isolation after July 2016
The IIDP is pleased to announce that the Human Islet Phenotyping Program (HIPP) database of phenotypic data on islet preparations is now available to approved IIDP investigators who have received islets from an isolation after July 2016.
The Human Islet Phenotyping Program (HIPP) of IIDP was established per NIH mandate in the summer of 2016. Through a peer-reviewed application process, the Vanderbilt Diabetes Center was selected as the program site. Since its inception, the HIPP has been directed by Dr. Marcela Brissova who is also director of the Islet Procurement and Analysis Core at the Vanderbilt Diabetes Research and Training Center.
The goal of this initiative is to provide standardized assessment of IIDP-contracted human islet preparations in order to understand the relationship between islet phenotypic features and key donor characteristics. Real-time and complementary data are currently available to the IIDP-affiliated Islet Isolation Centers and Investigators through a new IIDP-HIPP database. The database was jointly built by the teams at the City of Hope and Vanderbilt, and we hope it will become a valuable resource for the larger research community to advance our understanding of human islet biology in health and disease.
Number of views (1962)